TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Cypromed AS
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
3,668
|
3,412
|
3,299 |
| Financial expenses |
12
|
5
|
6 |
| Earnings before taxes |
576
|
563
|
658 |
| Total assets |
2,332
|
1,999
|
1,819 |
| Current assets |
2,266
|
1,929
|
1,721 |
| Current liabilities |
1,552
|
1,252
|
1,094 |
| Equity capital |
780
|
747
|
725 |
| - share capital |
50
|
53
|
56 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
33.4%
|
37.4%
|
39.9% |
| Turnover per employee | |||
| Profit as a percentage of turnover |
15.7%
|
16.5%
|
19.9% |
| Return on assets (ROA) |
25.2%
|
28.4%
|
36.5% |
| Current ratio |
146.0%
|
154.1%
|
157.3% |
| Return on equity (ROE) |
73.8%
|
75.4%
|
90.8% |
| Change turnover |
473
|
286
|
446 |
| Change turnover % |
15%
|
9%
|
16% |
| Chg. No. of employees | |||
| Chg. No. of employees % |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.